Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001628280-25-016067
Filing Date
2025-04-02
Accepted
2025-04-02 08:32:07
Documents
18

Document Format Files

Seq Description Document Type Size
1 424B4 gribio-march2025424b4.htm 424B4 1620507
2 business10aa.jpg GRAPHIC 44408
3 business11aa.jpg GRAPHIC 34482
4 business12aa.jpg GRAPHIC 565495
5 business13aa.jpg GRAPHIC 135604
6 business14aa.jpg GRAPHIC 201843
7 business15aa.jpg GRAPHIC 62450
8 business16aa.jpg GRAPHIC 110289
9 business2aa.jpg GRAPHIC 997690
10 business3aa.jpg GRAPHIC 149871
11 business4aa.jpg GRAPHIC 75661
12 business5aa.jpg GRAPHIC 124219
13 business6aa.jpg GRAPHIC 83695
14 business7aa.jpg GRAPHIC 43990
15 business8aa.jpg GRAPHIC 31742
16 business9aa.jpg GRAPHIC 39199
17 businessa.jpg GRAPHIC 307950
18 grilogo.jpg GRAPHIC 127122
  Complete submission text file 0001628280-25-016067.txt   5939569
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-286072 | Film No.: 25802281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)